Antithrombotic treatment and atrial fibrillation.
作者信息
Lowe G D
出版信息
BMJ. 1992 Dec 12;305(6867):1445-6. doi: 10.1136/bmj.305.6867.1445.
Abstract
摘要
相似文献
1
Antithrombotic treatment and atrial fibrillation.抗栓治疗与心房颤动
BMJ. 1992 Dec 12;305(6867):1445-6. doi: 10.1136/bmj.305.6867.1445.
2
Antithrombotic therapy in atrial fibrillation.心房颤动的抗栓治疗
Can Fam Physician. 1996 Jul;42:1341-5.
3
[Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy].[非瓣膜性原因所致心房颤动：抗血栓治疗指征]
Med Clin (Barc). 1996 Apr 20;106(15):586-9.
4
Warfarin in chronic atrial fibrillation in the elderly.华法林用于老年慢性心房颤动患者
Lancet. 1993 Jul 3;342(8862):48. doi: 10.1016/0140-6736(93)91907-4.
5
Warfarin, aspirin, and atrial fibrillation.华法林、阿司匹林与心房颤动。
Harv Heart Lett. 1998 Aug;8(12):4-6.
6
Warfarin in chronic atrial fibrillation.华法林用于慢性心房颤动
Lancet. 1993 May 29;341(8857):1376-7. doi: 10.1016/0140-6736(93)90945-d.
7
Atrial fibrillation and stroke. Three new studies, three remaining questions.心房颤动与中风。三项新研究，三个遗留问题。
Arch Intern Med. 1994 Jul 11;154(13):1443-8.
8
9
Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.大学医院心房颤动患者的抗栓治疗现状
Arch Intern Med. 1996 Nov 11;156(20):2311-6.
10
SPAF-III results.SPAF-III研究结果。
Eur Heart J. 1996 Jul;17(7):1129. doi: 10.1093/oxfordjournals.eurheartj.a015012.
引用本文的文献
1
Legal and professional implications of shared care: a case study in oral anticoagulation stroke prevention therapy.共享护理的法律和专业影响：口服抗凝剂预防中风治疗的案例研究
BMC Health Serv Res. 2015 Mar 10;15:93. doi: 10.1186/s12913-015-0756-9.
2
Patient self management of oral anticoagulation in routine care in the UK.英国常规护理中口服抗凝药的患者自我管理
J Clin Pathol. 2007 Nov;60(11):1263-7. doi: 10.1136/jcp.2006.044008. Epub 2007 Jan 26.
3
Oral anticoagulation control: the European perspective.口服抗凝控制：欧洲视角。
J Thromb Thrombolysis. 2006 Feb;21(1):95-100. doi: 10.1007/s11239-006-5584-7.
4
A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.口服抗凝治疗患者自我管理与初级保健管理的随机对照试验。
J Clin Pathol. 2002 Nov;55(11):845-9. doi: 10.1136/jcp.55.11.845.
5
Recommendations for patients undertaking self management of oral anticoagulation.口服抗凝剂自我管理患者的建议。
BMJ. 2001 Oct 27;323(7319):985-9. doi: 10.1136/bmj.323.7319.985.
6
Implementation of antithrombotic management in atrial fibrillation.心房颤动抗栓治疗的实施
Postgrad Med J. 2000 Dec;76(902):783-6. doi: 10.1136/pmj.76.902.783.
7
Evaluation of computerized decision support for oral anticoagulation management based in primary care.基于初级保健的口服抗凝管理计算机化决策支持评估。
Br J Gen Pract. 1996 Sep;46(410):533-5.
8
Physician variation in the management of patients with atrial fibrillation.心房颤动患者管理中的医生差异。
Heart. 1996 Feb;75(2):200-5. doi: 10.1136/hrt.75.2.200.
9
Methods for managing the increased workload in anticoagulant clinics.抗凝门诊应对工作量增加的管理方法。
BMJ. 1996 Feb 3;312(7026):286. doi: 10.1136/bmj.312.7026.286.
10
Introduction of computer assisted control of oral anticoagulation in general practice.全科医疗中口服抗凝治疗计算机辅助控制的介绍
J Clin Pathol. 1995 Dec;48(12):1144-6. doi: 10.1136/jcp.48.12.1144.
本文引用的文献
1
Duration of atrial fibrillation and imminence of stroke: the Framingham study.心房颤动持续时间与卒中紧迫性：弗雷明汉研究
Stroke. 1983 Sep-Oct;14(5):664-7. doi: 10.1161/01.str.14.5.664.
2
Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.
Stroke. 1983 Jul-Aug;14(4):537-40. doi: 10.1161/01.str.14.4.537.
3
Relation of atrial fibrillation and high haematocrit to mortality in acute stroke.急性卒中时房颤及高血细胞比容与死亡率的关系
Lancet. 1983 Apr 9;1(8328):784-6. doi: 10.1016/s0140-6736(83)91848-2.
4
Atrial fibrillation and antithrombotic prophylaxis: a prospective meta-analysis.心房颤动与抗血栓预防：一项前瞻性荟萃分析。
Lancet. 1989 Feb 11;1(8633):325-6. doi: 10.1016/s0140-6736(89)91332-9.
5
Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.华法林与阿司匹林预防慢性心房颤动血栓栓塞并发症的安慰剂对照随机试验。哥本哈根AFASAK研究。
Lancet. 1989 Jan 28;1(8631):175-9. doi: 10.1016/s0140-6736(89)91200-2.
6
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.心房颤动作为卒中的独立危险因素：弗雷明汉姆研究
Stroke. 1991 Aug;22(8):983-8. doi: 10.1161/01.str.22.8.983.
7
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.加拿大房颤抗凝（CAFA）研究
J Am Coll Cardiol. 1991 Aug;18(2):349-55. doi: 10.1016/0735-1097(91)90585-w.
8
Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.急性缺血性脑卒中及短暂性脑缺血发作中的抗血小板、抗凝及纤溶药物
Br J Hosp Med. 1992;47(10):731-7.
9
Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project).心房颤动与中风：不同类型中风中的患病率及其对早期和长期预后的影响（牛津郡社区中风项目）
BMJ. 1992 Dec 12;305(6867):1460-5. doi: 10.1136/bmj.305.6867.1460.
10
Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.心房颤动一级预防的成本效益：瑞典国家视角
BMJ. 1992 Dec 12;305(6867):1457-60. doi: 10.1136/bmj.305.6867.1457.
Zotero 插件